InsidersTradesSigma
우정바이오: management transactions · South Korea · DART (FSS)
DART:company-6784fcKR·DART (FSS)Mcap 46.7Bn€Healthcare
Browse the full insider trade history of 우정바이오, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 우정바이오 has recorded 2 public disclosures. Market capitalisation: €46.7bn. The latest transaction was disclosed on 3 April 2026 — Purchase. Among the most active insiders: 콜마홀딩스. Every trade is openly available.
2
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
2800.00 €
Analyst consensus
Income statement
Revenue37.59 Bn€
Gross profit10.10 Bn€27% margin
Net income−5.55 Bn€-14.8% margin
Valuation
Beta0.56
Balance sheet & cash
Market cap46.68 Bn€
Total debt50.52 Bn€
Free Cash Flow−889.8 M€
Debt / Equity216%
Profitability & ownership
ROE-21.0%
ROA-2.5%
% insiders39.3%
% institutions0.0%
Last declaration on 3 April 2026